Founder Trims Stake, US Growth & Reconstruction Approval

Establishment Labs founder Juan José Chacón Quirós sold approximately 105,000 shares, totaling $7.9 million, on May 6, 2026, due to a pre-set plan, not a reaction to earnings. He still holds over 970,000 shares, reducing his stake by around 10%. The company, known for advanced breast implants and surgical tools, saw US revenue surge 13.3% to $19.6 million in Q1 2026. Establishment Labs aims for free cash flow positivity by H2 2026 and has a reconstruction approval pending, potentially opening another revenue stream. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cc60d6fc0a4923f6